This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a quinazolinone core and a fluoro substituent, makes it valuable for developing potential therapeutic agents, particularly in the field of oncology. Researchers leverage its properties to design and optimize compounds that target specific enzymes or receptors involved in cancer cell proliferation. Additionally, its chiral center allows for the exploration of stereospecific interactions, which can enhance the efficacy and selectivity of drug candidates. The compound is also used in medicinal chemistry studies to investigate structure-activity relationships, aiding in the discovery of novel treatments for various diseases.